Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose insulin/glucose-potassium with or without magnesium for myocardial protection in urgent CABG surgery
2004-002850-69Phase 4Terminated
- Sponsor
- Swansea Bay University Health Board
- Start
- Aug 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of regular human insulin, dextrose, potassium chloride and magnesium sulfate in Myocardial injury (3 arms), sponsored by Swansea Bay University Health Board. Primary endpoints: Cardiac index and Troponin T. Started Aug 2005; status: terminated.
02
Drugs
regular human insulindextrosepotassium chloridemagnesium sulfate
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on 2004-002850-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002850-69.